Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Diego Holanda Lopes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cells|January 11, 2024
Promising and Minimally Invasive Biomarkers: Targeting MelanomaPavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Journal of Immunotherapy and Precision Oncology|November 11, 2024
A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future PerspectivesCarlos Diego Holanda Lopes, Camila Braganca Xavier, Carlos Torrado, et al.
Translational Oncology|March 6, 2022
Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysisCamila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, et al.
JCO Precision Oncology|December 10, 2025
Development and Validation of an Intratumor Heterogeneity-Based Prognostic Model for Clear Cell Renal Cell CarcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos, Mariana Macambira Noronha, et al.
Cancer Treatment Reviews|May 10, 2026
Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysisPedro C Abrahão Reis, Mariana Macambira Noronha, João Pedro Oliveira, et al.
European Journal of Hybrid Imaging|June 28, 2021
18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumorMarcello Moro Queiroz, Carlos Diego Holanda Lopes, Alessandra Corte Real Salgues, et al.
Case Reports in Oncology|April 18, 2022
Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN GeneBeatriz Mendes Awni, Carlos Diego Holanda Lopes, Guilherme Harada, et al.
SAGE Open Medical Case Reports|May 27, 2022
Unique <i>SLC12A2-ROS1</i> fusion is associated with marked response to crizotinib in lung adenocarcinomaMaurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo, et al.
NPJ Precision Oncology|May 5, 2026
Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profilingCarlos Diego Holanda Lopes, Hsin-Ta Wu, Katharine Dilger, et al.
Frontiers in Oncology|March 14, 2022
A Novel Murine Model of a High Dose Brachytherapy-Induced Actinic ProctitisCarlos Heli Bezerra Leite, Carlos Diego Holanda Lopes, Caio Abner Vitorino Gonçalves Leite, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cells|January 11, 2024
Promising and Minimally Invasive Biomarkers: Targeting MelanomaPavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico
Journal of Immunotherapy and Precision Oncology|November 11, 2024
A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future PerspectivesCarlos Diego Holanda Lopes, Camila Braganca Xavier, Carlos Torrado, et al.
Translational Oncology|March 6, 2022
Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysisCamila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, et al.
JCO Precision Oncology|December 10, 2025
Development and Validation of an Intratumor Heterogeneity-Based Prognostic Model for Clear Cell Renal Cell CarcinomaValbert Oliveira Costa Filho, Pedro Robson Costa Passos, Mariana Macambira Noronha, et al.
Cancer Treatment Reviews|May 10, 2026
Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysisPedro C Abrahão Reis, Mariana Macambira Noronha, João Pedro Oliveira, et al.
European Journal of Hybrid Imaging|June 28, 2021
18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumorMarcello Moro Queiroz, Carlos Diego Holanda Lopes, Alessandra Corte Real Salgues, et al.
Case Reports in Oncology|April 18, 2022
Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN GeneBeatriz Mendes Awni, Carlos Diego Holanda Lopes, Guilherme Harada, et al.
SAGE Open Medical Case Reports|May 27, 2022
Unique <i>SLC12A2-ROS1</i> fusion is associated with marked response to crizotinib in lung adenocarcinomaMaurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo, et al.
NPJ Precision Oncology|May 5, 2026
Predicting immunotherapy benefit in leiomyosarcoma through active chromatin cfDNA profilingCarlos Diego Holanda Lopes, Hsin-Ta Wu, Katharine Dilger, et al.
Frontiers in Oncology|March 14, 2022
A Novel Murine Model of a High Dose Brachytherapy-Induced Actinic ProctitisCarlos Heli Bezerra Leite, Carlos Diego Holanda Lopes, Caio Abner Vitorino Gonçalves Leite, et al.
Pageof 2